Skip to content

    Recently Viewed

      Listening...

      Ethicon Debuts an AI-powered Laparoscopic Skills Training Platform at the American Association of Gynecological Laparoscopists Global Congress

      First-of-its-kind device to seamlessly integrate augmented reality, AI-guided assessment, and tactile feedback to enhance the surgical skills and training experiences for general, gynecological, and laparoscopic surgeons

      Share Article
      share to

      CINCINNATI, OH – November 6, 2023 – Ethicon*, a Johnson & Johnson MedTech** company, today debuted an AI-powered Surgical Simulation Platform that supports skill development in current and future surgeons at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. The technology ushers in a new era in surgical training by leveraging artificial intelligence (AI), and augmented reality (AR) powered trainings, real-time data, and tactical feedback.

      While demand for surgical training remains high, access to quality education can be challenging due to staffing shortages, time constraints, and space limitations. The new Ethicon Laparoscopic Skills Training Platform offers a connected digital learning experience that is highly portable, adaptable to the learner’s evolving circumstances, and effortlessly integrated into their everyday quality education and training routines.

      “We understand the challenges faced by today’s surgeons and surgical residents in their professional education journey, including issues related to accessibility and the vital tactile feedback needed for the development of cognitive and psychomotor skills,” said Vishnu Kalra, president of Ethicon U.S. “This understanding drove our partnership and the creation of an innovative solution that leverages technology to address these barriers and enhance the learning experience to improve patient outcomes.”

      The Ethicon Laparoscopic Skills Training Platform is the latest example of the company’s commitment to delivering personalized and innovative education, expanding reach, and deepening knowledge beyond traditional training experiences. The platform has built-in learning courses that combine tactile skill building with intelligent learning technology to provide evidence-based cognitive and psychomotor skill development. It also includes fundamental surgical training tasks for individual surgeons to hone in on essential skills and techniques as the device detects shapes, orientations, and much more to provide real-time, objective feedback.

      Ethicon will debut the platform at the annual AAGL meeting in Nashville, TN. The company plans to pilot the program across academic health systems in the U.S.

      For more information about Ethicon’s strategic collaborations, its commitment to advancing surgical innovation, and access to on-demand training, please visit Future Leaders | Johnson & Johnson Institute

      About Ethicon

      At Ethicon, a Johnson & Johnson MedTech company, putting humanity at the core of care is our passion and our purpose. In collaboration with clinicians and healthcare experts around the world, we develop clinically differentiated surgical technologies and solutions to help address some of the most pressing health challenges of our time, such as metabolic disease, cardiovascular disease, and cancer. Through our efforts and ingenuity, we aspire to elevate standards of care and create a healthier future for the patients of today and tomorrow. Visit www.ethicon.com to learn more about us.

      About Johnson & Johnson MedTech

      At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

      Cautions Concerning Forward-Looking Statements

      This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the AI-powered Laparoscopic Skills Training Platform. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Ethicon, Inc., and/or Johnson & Johnson. Risks and uncertainties include but are not limited to changes to applicable laws and regulations, including global health care reforms, changes in behavior and spending patterns of purchasers of health care products and services. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 1, 2023, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither Ethicon, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.

      *Ethicon represents the products and services of Ethicon, Inc., and certain of their affiliates. All other trademarks are the property of their respective owners.

      **Johnson & Johnson MedTech comprises the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson’s MedTech segment.

      ©Ethicon US, LLC. 2023. All Rights Reserved. US_ETH_ALLE_300066

      Media Contact:
      Carlos Taveras
      CTaveras@ITS.JNJ.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.